Alnylam's CEO Says She's Ready to Take Over From Biotech Legend

10:23am PST - January 7th, 2022    logan paul - Bloomberg

Yvonne Greenstreet was sitting on a plane at Boston Logan International Airport waiting to take off in 2018 when U.S. regulators approved Alnylam Pharmaceuticals Inc.’s first drug, Onpattro. The chief operating officer grabbed her carry-on from the overhead b…